Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Osteosarcoma is the most common primary bone malignancy in adolescents. Its high
propensity to metastasize is the leading cause for treatment failure and poor prognosis …

Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-
CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal …

Osteosarcomas (OSs) are bone tumors most commonly found in pediatric and adolescent
patients characterized by high risk of metastatic progression and recurrence after therapy …

Osteosarcoma patient survival has remained stagnant for 30 years. Novel therapeutic
approaches are needed to improve outcomes. We examined the expression of Programmed …

Osteosarcoma is a rare primary bone cancer characterized by cancer cells producing
calcified osteoid extracellular matrix and inducing lung metastases with a high frequency …

Osteosarcoma (OS), which occurs most commonly in adolescents, is associated with a high
degree of malignancy and poor prognosis. In order to develop an accurate treatment for OS …

Osteosarcoma (OS) pulmonary metastasis translates into poor patient survival. The
implication of PD‐1‐PD‐L1 pathway in the context of NK cells and/or macrophages in OS is …

Background Osteosarcoma (OS) is the most common primary malignant bone tumor.
Compared with previous treatment modalities, such as amputation, more recent …

The French phase 3 trial (OS 2006) testing zoledronic acid, an osteoclast inhibitor, with
chemotherapy and surgery did not improve the outcome of patients with osteosarcoma (OS) …